Oluwafunmilayo Adenuga

Oluwafunmilayo Adenuga

Auto-generated profile, based on publicly available information

Oluwafunmilayo Adenuga

Department of medicine and surgery, university of Lagos, Lagos State, Nigeria

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2025 in Australian Journal of Biomedical Research
Verified
Journal Article
Open access
PDF file
VNVivian Ukamaka Nwokedi
Vivian Ukamaka Nwokedi
EOEnibokun Theresa Orobator
Enibokun Theresa Orobator
OAOlukunle O Akanbi
Olukunle O Akanbi
JSJosiah Stephen
Josiah Stephen
OAOluwafunmilayo Adenuga
Oluwafunmilayo Adenuga
AOAmber Otibhor Omoike
Amber Otibhor Omoike
Background: Personalised medicine through pharmacogenomics is revolutionalizing healthcare delivery by encouraging individualized therapy that takes into consideration an individual's genetic profile, environment and lifestyle. Pharmacogenomics is an aspect of pharmacy that studies the relationship between genetic profile and response to therapeutic agents. However, the application of the concepts of pharmacogenomics in healthcare helps in achieving more effective and safe responses from therapy. This study evaluates the application and benefits of pharmacogenomics in clinical practice based on evidence from current practices in various medical fields. Methods: In carrying out this review, PubMed database was the primary literature source and we analyzed and synthesized findings from the included literature thematically as it relates to pharmacogenomics applications, benefits and challenges as well as safety and ethical concerns. Results: Pharmacogenomics has been widely applied in various aspects of healthcare such as in dosing, choice of treatment, reducing and management of adverse reactions, individualization of therapy, optimizing efficacy of therapy. Despite its numerous applications, its adoption faces challenges such as limited clinical evidence, lack of specialized training among healthcare professionals, cost and complexity of genetic mapping as well as ethical concerns. Conclusion: With ongoing advances in genomic technologies, pharmacogenomics is becoming an integral aspect of individualization therapy in clinical practice and more widely applied in different healthcare sectors.